Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth.

MLA

Yan, Yan, et al. “Dopamine Receptor D3 Is Related to Prognosis in Human Hepatocellular Carcinoma and Inhibits Tumor Growth.” BMC Cancer, vol. 22, no. 1, Dec. 2022, p. 1248. EBSCOhost, https://doi.org/10.1186/s12885-022-10368-y.

APA

Yan, Y., Chen, Y., Pan, J., Xing, W., Li, Q., Wang, Y., Gei, L., Yuan, Y., Xie, J., Zeng, W., & Chen, D. (2022). Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth. BMC Cancer, 22(1), 1248. https://doi.org/10.1186/s12885-022-10368-y

Chicago

Yan, Yan, Yonghua Chen, Jiahao Pan, Wei Xing, Qiang Li, Yan Wang, Liba Gei, et al. 2022. “Dopamine Receptor D3 Is Related to Prognosis in Human Hepatocellular Carcinoma and Inhibits Tumor Growth.” BMC Cancer 22 (1): 1248. doi:10.1186/s12885-022-10368-y.